Aneurysm Coiling & Embolization Devices Segment Projected to Lead Market Growth Through 2027
According to a recent market research study titled “North America Neurovascular Devices Market Forecast to 2027 – COVID-19 Impact and Analysis by Product, Application, and End User,” the North America neurovascular devices market is projected to grow from US$ 1,004.75 million in 2019 to US$ 1,389.28 million by 2027, expanding at a compound annual growth rate (CAGR) of 4.2% from 2020 to 2027. The report highlights key market trends, growth drivers, and potential challenges impacting market dynamics.
📚𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 – https://www.businessmarketinsights.com/sample/TIPRE00016226
Based on product segmentation, the market includes neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, and support devices. Among these, aneurysm coiling & embolization devices dominated the market in 2019 and are expected to register the highest CAGR during the forecast period, maintaining their leading position.
Neurovascular devices are critical in the treatment of various neurovascular disorders that affect the brain’s blood vessels, including conditions such as strokes and cerebral aneurysms. These devices play a vital role in procedures aimed at stroke prevention, aneurysm embolization, and treatment of carotid artery stenosis. In particular, the increasing prevalence of cerebral aneurysms is fueling market demand. In the United States alone, approximately 30,000 individuals experience brain aneurysm ruptures annually—translating to one rupture every 18 minutes. The estimated rupture rate stands at around 8 to 10 per 100,000 people per year.
Key Market Drivers:
- Rising incidence of neurovascular diseases
- Increasing demand for minimally invasive procedures
- Growing geriatric population prone to neurological conditions
Market Challenges:
- High cost of embolization coils
- Shortage of skilled professionals to manage complex neurovascular procedures
Despite some hindering factors, the market outlook remains positive, driven by technological advancements and the growing burden of cerebrovascular conditions across North America.
The report segments in North America Neurovascular Devices Market as follows:
| Category | Subcategories |
| By Product | Neurothrombectomy Devices, Clot Retrieval Devices, Suction & Aspiration Devices, Snares, Aneurysm Coiling & Embolization Devices, Flow Diversion Devices, Liquid Embolic Agents, Cerebral Balloon Angioplasty & Stenting Systems, Embolic Protection Systems, Support Devices |
| Embolization Subtypes | Embolic Coils, Bare Detachable Coils, Coated Detachable Coils |
| Protection Systems Subtypes | Balloon Occlusion Devices, Distal Fillers |
| Support Devices Subtypes | Microcatheters, Microguidewires |
| By Application | Cerebral Aneurysms, Arteriovenous Malformation & Fistulas, Other Applications |
| By End User | Hospitals, Ambulatory Surgical Centers, Specialized Clinics |
| By Country | US, Canada, Mexico |
Strategic Insights: North America Neurovascular Devices Market
Strategic insights into the North American neurovascular devices market offer a data-driven understanding of the current industry landscape, highlighting emerging trends, leading players, and regional dynamics. These insights provide practical recommendations that enable stakeholders to stand out from competitors by identifying underserved market segments and crafting distinct value propositions.
By leveraging advanced data analytics, these insights equip investors, manufacturers, and other stakeholders with the tools to anticipate market evolution and respond proactively to shifts. With a forward-looking approach, businesses can align their strategies for long-term growth and resilience in this rapidly evolving sector.
Ultimately, these strategic insights support informed decision-making, helping industry players enhance profitability, achieve business goals, and secure a competitive edge in the North American neurovascular devices market.
Regional Insights for Neurovascular Devices in North America
The North American market for neurovascular devices encompasses a range of distinct regional dynamics that businesses must consider to compete effectively. Local variations—such as differences in patient needs, healthcare infrastructure, regulatory requirements, and economic conditions—play a critical role in shaping market strategies. For example, demand may vary based on preferences for specific device features, such as plug types or battery backup capabilities. By recognizing and responding to these regional distinctions, companies can better serve local markets, identify underserved areas, and tailor their products or services accordingly. This localized approach enables more strategic resource allocation, enhances the effectiveness of marketing efforts, and strengthens competitive positioning—ultimately fostering sustainable growth across the region.
Market Overview and Dynamics
The North America neurovascular devices market is projected to grow from US$ 1,004.75 million in 2019 to US$ 1,389.28 million by 2027, registering a compound annual growth rate (CAGR) of 4.2% during the forecast period (2020–2027).
Key drivers fueling this market growth include the rising prevalence of neurovascular diseases, an increasing preference for minimally invasive procedures, and a rapidly expanding aging population. Despite these positive trends, the market is anticipated to experience a slower growth trajectory due to challenges such as the high cost of embolization coils and a shortage of skilled professionals specializing in neurovascular interventions.
Key Market Segments
The North America neurovascular devices market is segmented by product, application, and end user.
By Product:
The market is categorized into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, and support devices. Among these, aneurysm coiling & embolization devices accounted for the largest market share in 2019 and are projected to record the highest compound annual growth rate (CAGR) during the forecast period.
By Application:
Applications of neurovascular devices include treatment of cerebral aneurysms, ischemic strokes, arteriovenous malformations & fistulas, and other conditions. In 2019, the ischemic strokes segment led the market in terms of share and is also expected to grow at the fastest rate over the forecast period.
By End User:
The market is further segmented into hospitals, ambulatory surgical centers, and specialized clinics. Hospitals dominated the market in 2019, holding the largest share, and are expected to maintain their lead with the highest CAGR throughout the forecast period.
North America North America Neurovascular Devices market –
| Category | Subcategories |
| By Product | Neurothrombectomy Devices, Clot Retrieval Devices, Suction & Aspiration Devices, Snares, Aneurysm Coiling & Embolization Devices (Embolic Coils, Bare Detachable Coils, Coated Detachable Coils), Flow Diversion Devices, Liquid Embolic Agents, Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents, Embolic Protection Systems, Balloon Occlusion Devices, Distal Fillers), Support Devices (Microcatheters, Microguidewires) |
| By Application | Cerebral Aneurysms, Arteriovenous Malformation & Fistulas, Other Applications |
| By End User | Hospitals, Ambulatory Surgical Centers, Specialized Clinics |
| By Country | US, Canada, Mexico |
| Company Profiles | Medtronic plc, Johnson & Johnson (DePuy Synthes), Penumbra, Terumo, MicroPort, Integer Holdings, Memry Corp, Phenox GmbH |
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
